PELI BIOTHERMAL LIMITED
Get an alert when PELI BIOTHERMAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-01-06 (in 8mo)
Last made up 2025-12-23
Watchouts
None on the register
Cash
£6M
+100.1% vs 2023
Net assets
£37M
+3.7% vs 2023
Employees
124
-2.4% vs 2023
Profit before tax
£2M
+875% vs 2023
Name history
Renamed 1 time since incorporation
- PELI BIOTHERMAL LIMITED 2014-09-22 → present
- PELI COOL LOGISTICS LIMITED 2013-12-23 → 2014-09-22
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £55,877,649 | £52,694,034 | |
| Operating profit | -£270,603 | £1,589,011 | |
| Profit before tax | -£222,248 | £1,722,489 | |
| Net profit | -£161,041 | £1,294,774 | |
| Cash | £2,824,614 | £5,652,550 | |
| Total assets less current liabilities | £44,330,516 | £45,764,126 | |
| Net assets | £35,238,947 | £36,533,721 | |
| Equity | £35,238,947 | £36,533,721 | |
| Average employees | 127 | 124 | |
| Wages | £5,566,498 | £6,002,499 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -0.5% | 3.0% | |
| Net margin | -0.3% | 2.5% | |
| Return on capital employed | -0.6% | 3.5% | |
| Gearing (liabilities / total assets) | 34.2% | 41.3% | |
| Current ratio | 5.02x | 3.37x | |
| Interest cover | -0.93x | 2.77x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Directors have prepared cash flow forecasts and identified no material adverse effects on financial position, results of operations, and cash flows. Management will continue to monitor and evaluate circumstances for the foreseeable future, concluding that the going concern basis is appropriate.”
Significant events
- “The annual corporate plan was approved following a robust and comprehensive review process. It was decided the plan would promote the success of the Company.”
- “The introduction of the new Vault bulk shipper expanding the rental offer available to customers”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SECRETARIAL APPOINTMENTS LIMITED | Corporate Secretary | 2013-12-23 | — | — |
| KRAVETS, Michael David | Director | 2024-02-21 | Apr 1973 | American |
| ROSS, Douglas Steven | Director | 2024-06-19 | Feb 1971 | American |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FAULKNER, Lyndon John | Director | 2013-12-23 | 2020-09-07 |
| GYORI, Philip | Director | 2019-07-18 | 2023-07-12 |
| JORDAN, Donald Ervin, Mr. | Director | 2013-12-23 | 2018-11-02 |
| MARIGO, Piero | Director | 2013-12-23 | 2024-06-19 |
| PLATISA, George | Director | 2019-07-18 | 2019-07-18 |
| PLATISA, George Charles | Director | 2019-07-18 | 2024-02-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Peli Biopharma S.L.U. | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2016-04-06 |
Filing timeline
Last 20 of 49 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-24 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-01-23 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2026-01-16 | CH01 | officers | Change person director company with change date | |
| 2025-12-28 | AA | accounts | Accounts with accounts type full | |
| 2025-02-25 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2025-02-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-01-13 | CH04 | officers | Change corporate secretary company with change date | |
| 2025-01-08 | AA | accounts | Accounts with accounts type full | |
| 2025-01-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-06-26 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-26 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-23 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-19 | AA | accounts | Accounts with accounts type full | |
| 2024-01-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-27 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-09 | AA | accounts | Accounts with accounts type full | |
| 2022-12-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-05-20 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-5.7%
£55,877,649 £52,694,034
-
Cash
+100.1%
£2,824,614 £5,652,550
-
Net assets
+3.7%
£35,238,947 £36,533,721
-
Employees
-2.4%
127 124
-
Operating profit
+687.2%
-£270,603 £1,589,011
-
Profit before tax
+875%
-£222,248 £1,722,489
-
Wages
+7.8%
£5,566,498 £6,002,499
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers